SEC Form 4 · accession 0001127602-18-009302

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · CRL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chairman & CEO · Director

Period of report

Feb 27, 2018

Accepted (ET)

Mar 1, 2018 · 12:35 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001100682

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Feb 27, 2018	S	100	$108.03	D	315,614	D
Common Stock	Feb 27, 2018	S	300	$108.04	D	315,314	D
Common Stock	Feb 27, 2018	S	200	$108.05	D	315,114	D
Common Stock	Feb 27, 2018	S	100	$108.055	D	315,014	D
Common Stock	Feb 27, 2018	S	300	$108.06	D	314,714	D
Common Stock	Feb 27, 2018	S	700	$108.08	D	314,014	D
Common Stock	Feb 27, 2018	S	100	$108.085	D	313,914	D
Common Stock	Feb 27, 2018	S	200	$108.09	D	313,714	D
Common Stock	Feb 27, 2018	S	200	$108.10	D	313,514	D
Common Stock	Feb 27, 2018	S	100	$108.105	D	313,414	D
Common Stock	Feb 27, 2018	S	200	$108.11	D	313,214	D
Common Stock	Feb 27, 2018	S	400	$108.12	D	312,814	D
Common Stock	Feb 27, 2018	S	600	$108.13	D	312,214	D
Common Stock	Feb 27, 2018	S	267	$108.14	D	311,947	D
Common Stock	Feb 27, 2018	S	200	$108.15	D	311,747	D
Common Stock	Feb 27, 2018	S	200	$108.17	D	311,547	D
Common Stock	Feb 27, 2018	S	500	$108.175	D	311,047	D
Common Stock	Feb 27, 2018	S	100	$108.20	D	310,947	D
Common Stock	Feb 27, 2018	S	300	$108.205	D	310,647	D
Common Stock	Feb 27, 2018	S	300	$108.21	D	310,347	D
Common Stock	Feb 27, 2018	S	300	$108.22	D	310,047	D
Common Stock	Feb 27, 2018	S	600	$108.23	D	309,447	D
Common Stock	Feb 27, 2018	S	300	$108.24	D	309,147	D
Common Stock	Feb 27, 2018	S	500	$108.25	D	308,647	D

No Table II lines on this filing.